Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau

Written By Yiran Gan
Associations Between Blood-Based Biomarkers of Alzheimer's Disease with Cognition in Motoric Cognitive Risk Syndrome: A Pilot Study Using Plasma Aβ42 and Total Tau - Chen et al. 2023

Associations Between Blood-Based Biomarkers of Alzheimer's Disease with Cognition in Motoric Cognitive Risk Syndrome: A Pilot Study Using Plasma Aβ42 and Total Tau

Publication Date: 2022.10.4

Authors: Pei-Hao Chen, Sang-I Lin, Ying-Yi Liao, Wei-Ling Hsu and Fang-Yu Cheng

Journal: Frontiers in Aging Neuroscience, 04 October 2022

© 2022 Chen, Lin, Liao, Hsu and Cheng

Frontiers in Aging Neuroscience

Yiran Gan
Previous

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Next

Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial